| Adenoviral vector immunity: its implications and circumvention strategies Y S Ahi, D S Bangari, S K Mittal Current gene therapy 11 (4), 307-320, 2011 | 247 | 2011 |
| Components of Adenovirus Genome Packaging YS Ahi, SK Mittal Frontiers in Microbiology 7, 1503, 2016 | 134 | 2016 |
| Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus … YS Ahi, S Zhang, Y Thappeta, A Denman, A Feizpour, S Gummuluru, ... mBio 7 (6), e01985-16, 2016 | 64 | 2016 |
| Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses A Sharma, M Tandon, YS Ahi, DS Bangari, R Vemulapalli, SK Mittal Gene therapy 17 (5), 634-642, 2010 | 57 | 2010 |
| Effective protection by high efficiency bicistronic DNA vaccine against infectious bursal disease virus expressing VP2 protein and chicken IL-2 S Kumar, YS Ahi, SS Salunkhe, M Koul, AK Tiwari, PK Gupta, A Rai Vaccine 27 (6), 864-869, 2009 | 56 | 2009 |
| Broadly Protective Adenovirus-Based Multivalent Vaccines against Highly Pathogenic Avian Influenza Viruses for Pandemic Preparedness SV Vemula, YS Ahi, AM Swaim, JM Katz, R Donis, S Sambhara, SK Mittal PloS one 8 (4), e62496, 2013 | 52 | 2013 |
| Adenoviral E2 IVa2 protein interacts with L4 33K protein and E2 DNA-binding protein YS Ahi, SV Vemula, SK Mittal Journal of General Virology 94 (6), 1325-1334, 2013 | 37 | 2013 |
| Adenoviral E2 IVa2 protein interacts with L4 33K protein and E2 DNA-binding protein YS Ahi, SV Vemula, SK Mittal American Society for Virology Annual Meeting 31, P6-2, 2012 | 37 | 2012 |
| EphrinA1–EphA2 interaction‐mediated apoptosis and FMS‐like tyrosine kinase 3 receptor ligand‐induced immunotherapy inhibit tumor growth in a breast cancer mouse model M Tandon, SV Vemula, A Sharma, YS Ahi, S Mittal, DS Bangari, SK Mittal The journal of gene medicine 14 (2), 77-89, 2012 | 28 | 2012 |
| Adenoviral L4 33K forms ring-like oligomers and stimulates ATPase activity of IVa2: implications in viral genome packaging YS Ahi, SV Vemula, AO Hassan, G Costakes, C Stauffacher, SK Mittal Frontiers in Microbiology 6, 2015 | 26 | 2015 |
| Adenoviral E4 34K protein interacts with virus packaging components and may serve as the putative portal YS Ahi, AO Hassan, SV Vemula, K Li, W Jiang, GJ Zhang, SK Mittal Scientific Reports 7 (1), 7582, 2017 | 16 | 2017 |
| Adenoviral Vectors: Potential and Challenges as a Gene Delivery System SK Mittal, AM Swaim, YS Ahi Viral Gene Therapy, 2011 | 2 | 2011 |
| A bivalent mammalian expression vector encoding two rabies glycoprotein genes induces enhanced immunity and protection. YS Ahi, A Rai, PK Gupta, AK Tiwari, SS Salunkhe, S Kumar, A Saxena, ... Indian Journal of Virology 19 (1), 1-8, 2008 | 2 | 2008 |
| Modulation by Serinc Proteins of Retroviral and Ebolavirus Glycoprotein-Mediated Entry YS Ahi, J Manzi, D Yimer, S Zhang, J Acharya, E Freed, A Rein Retroviruses Annual Meeting Cold Spring Harbor 42, 51, 2017 | | 2017 |
| Glycogag and serinc5 modulate murine leukemia virus entry: opposite effects on gammaretroviral and ebolavirus glycoproteins YS Ahi, S Zhang, Y Thappeta, A Denman, A Feizpour, S Gummuluru, ... International Workshop on Retroviral Pathogenesis 28, 58, 2016 | | 2016 |
| Functional Interplay between Murine Leukemia Virus Glycogag, Surface Glycoprotein and Serinc5 Modulates Virus Entry YS Ahi, S Zhang, D Muriaux, A Feizpour, B Reinhard, R Gummuluru, ... Structural Biology Related to HIV/AIDS 2016, T10, 2016 | | 2016 |
| Functional Interaction of Murine Leukemia Virus Glycogag and Surface Glycoprotein Impacts Virus Entry YS Ahi, S Zhang, D Muriaux, A Feizpur, B Reinhard, R Gummuluru, ... Retroviruses Annual Meeting Cold Spring Harbor 41, 11, 2016 | | 2016 |
| Investigating Function of Glycogag in Murine Leukemia Virus Life Cycle YS Ahi, J Mirro, A Rein Retroviruses Annual Meeting Cold Spring Harbor 39, 272, 2014 | | 2014 |
| Evaluation of cross reactive humoral and cell-mediated immunity among human, bovine and porcine adenoviral vectors A Sharma, M Tandon, YS Ahi, DS Bangari, R Vemulapalli, SK Mittal American Society of Gene Therapy Annual Meeting 17 (1), S1, 2009 | | 2009 |
Sai Vikram VemulaMerck, KenilworthVerified email at merck.com
